Skip to content

CONEXUS PHARMA

Absorbed by REGON on 30-01-2018 KBO/BCE: BE 0538.611.801 subsidiary of REGON

Timeline

9 events since 2013
2018
Merger: absorbed by REGONDissolution of the company · Dissolved without liquidation · Books and records kept by REGON · General meeting of 23-10-20173 points ▸
  • General meeting, 23-10-2017
  • REGON holds all the shares
  • Accounting effect, 01-06-2017
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

2017
Merger proposal: to be absorbed by Bvba Regon and act as permanent representatives · Bvba Regon holds all the shares8 points ▸
  • Bvba Regon holds all the shares
  • Board composition, (director)
  • Board composition, (director)
  • Board composition, Bvba Regon (director)
  • Board composition, (director)
  • Permanent representative,
  • Permanent representative,
  • Accounting effect, 01-06-2017
  • The deed holds 15 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFmicro format · 1 day late
2016
Liquidity more than 13 times current ratio 15.69 The current ratio rises from 1.18 to 15.69. Short-term debt falls from €9,054 to €958.
Annual accounts 2015 filed PDFabbreviated format · 2 days before the deadline
2015
Weakest financial year net -€36,198 The net result drops to -€36,198, the lowest from 2014 to 2016.
Annual accounts 2014 filed PDFabbreviated format · 4 days late
2014
4 directors appointed (managing director), , REGON and · and act as permanent representatives7 points ▸
  • Director appointment,
  • Director appointment,
  • Director appointment, REGON
  • Director appointment,
  • Permanent representative,
  • Permanent representative,
  • Director appointment, (managing director)
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

2013
IncorporationFounded by , , REGON and 2 others · Founding capital of €61,500, 10,000 shares · (managing director), , REGON and appointed16 points ▸
  • Incorporation, 30-08-2013
  • Founder,
  • Founder,
  • Power of attorney, , mentioned twice in the deed
  • Founder,
  • Founder,
  • Founder, REGON
  • Founding capital, €61,500, 10,000 shares
  • Capital, €61,500, 10,000 shares
  • Director appointment,
  • Director appointment,
  • Director appointment, REGON
  • Director appointment,
  • Permanent representative,
  • Permanent representative,
  • Director appointment, (managing director)
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

The deed of incorporation of CONEXUS PHARMA was published in the Belgian Official Gazette on 24 September 2013.1 The company has filed 3 sets of annual accounts, the latest for financial year 2016.2 In 2018 the company was absorbed by merger into REGON.3

  1. 1Belgian Official Gazette, 24-09-2013
  2. 2National Bank, annual accounts 2016
  3. 3Belgian Official Gazette, 30-01-2018